Rohit Singh, MD
Assistant Professor of Medicine, Division of Hematology and Oncology
Medical Oncologist, UVM Health Network
- MB, BS, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences
Department of Medicine, Division of Hematology and Oncology
University of Vermont Cancer Center
Hematology and Oncology, University of Vermont Health Network-Main Campus
Hematology and Oncology, Central Vermont Medical Center
BIO
I am a medical oncologist and faculty member at UVM. I am strongly interested in immunotherapy, lung cancer, and melanoma. My clinical work and research focus on understanding how the immune system can be harnessed to fight cancer more effectively. I particularly emphasize the role of diet and the microbiome in shaping responses to immunotherapy. Emerging evidence suggests that gut bacteria and dietary factors can influence how well patients respond to immune-based treatments, and my work explores these interactions to optimize therapy outcomes. I completed my Internal Medicine residency at Yale-Waterbury Hospital in CT and subsequently pursued a Hematology/Oncology fellowship at the University of Vermont (UVM), where I developed my expertise in medical oncology, immunotherapy, and supportive care. In addition to advancing treatment strategies, I am deeply committed to supportive care and the role of palliative care, ensuring that patients receive cutting-edge treatments and have access to comprehensive, symptom-focused management throughout their cancer journey. My published research includes work on the efficacy of immunotherapy in patients with gut microbiome altering medications, prognostic classification for patients with brain metastases from solid tumors, and a focus on improving patient outcomes through palliative and supportive care interventions. Beyond research, I am actively engaged in oncology policy and advocacy and participated in ASCO advocacy efforts to promote policies that improve access to cancer care and clinical trials. Through a combination of clinical care, research, and advocacy, I strive to enhance cancer treatment and ensure that all patients benefit from the latest advances in oncology.
Dr. Singh's postdoctoral training
- Hematology Oncology Fellow University of Vermont Medical Center
- Resident Physician, Internal Medicine Yale New Haven Medical Center (Waterbury)
- Research Assistant Yale-New Haven Hospital
- Resident Medical Officer Medanta, The Medicity Gurgaon, India
Dr. Singh's professional associations
- American Society of Clinical Oncology
- NNECOS
- American Society of Hematology
- American College of Physicians
- European Society of Medical Oncology
- International Association for the Study of Lung Cancer (IASLC)
- Society for Immunotherapy of Cancer (SITC)
Publications
Bio
I am a medical oncologist and faculty member at UVM. I am strongly interested in immunotherapy, lung cancer, and melanoma. My clinical work and research focus on understanding how the immune system can be harnessed to fight cancer more effectively. I particularly emphasize the role of diet and the microbiome in shaping responses to immunotherapy. Emerging evidence suggests that gut bacteria and dietary factors can influence how well patients respond to immune-based treatments, and my work explores these interactions to optimize therapy outcomes. I completed my Internal Medicine residency at Yale-Waterbury Hospital in CT and subsequently pursued a Hematology/Oncology fellowship at the University of Vermont (UVM), where I developed my expertise in medical oncology, immunotherapy, and supportive care. In addition to advancing treatment strategies, I am deeply committed to supportive care and the role of palliative care, ensuring that patients receive cutting-edge treatments and have access to comprehensive, symptom-focused management throughout their cancer journey. My published research includes work on the efficacy of immunotherapy in patients with gut microbiome altering medications, prognostic classification for patients with brain metastases from solid tumors, and a focus on improving patient outcomes through palliative and supportive care interventions. Beyond research, I am actively engaged in oncology policy and advocacy and participated in ASCO advocacy efforts to promote policies that improve access to cancer care and clinical trials. Through a combination of clinical care, research, and advocacy, I strive to enhance cancer treatment and ensure that all patients benefit from the latest advances in oncology.
Dr. Singh's postdoctoral training
- Hematology Oncology Fellow University of Vermont Medical Center
- Resident Physician, Internal Medicine Yale New Haven Medical Center (Waterbury)
- Research Assistant Yale-New Haven Hospital
- Resident Medical Officer Medanta, The Medicity Gurgaon, India
Dr. Singh's professional associations
- American Society of Clinical Oncology
- NNECOS
- American Society of Hematology
- American College of Physicians
- European Society of Medical Oncology
- International Association for the Study of Lung Cancer (IASLC)
- Society for Immunotherapy of Cancer (SITC)